Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13735 | 29785077 | World J Gastroenterol | Mediterranean diet and nonalcoholic fatty liver disease. | 2018 | Details |
| A13740 | 29781841 | Curr Opin Clin Nutr Metab Care | Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents. | 2018 | Details |
| A13744 | 29779170 | Eur J Nutr | Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. | 2018 | Details |
| A13745 | 29779083 | Dig Dis Sci | Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. | 2018 | Details |
| A13767 | 29766801 | Curr Pharm Biotechnol | Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective. | 2018 | Details |
| A13768 | 29766791 | Curr Pharm Des | Immunometabolic Changes in Hepatocytes Arising from Obesity and the Practice of Physical Exercise. | 2018 | Details |
| A13819 | 29743560 | Cell Death Differ | Caspases in metabolic disease and their therapeutic potential. | 2018 | Details |
| A13832 | 29735796 | Ann Hepatol | Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis. | 2018 | Details |
| A13839 | 29733805 | J Pediatr (Rio J) | IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease. | 2018 | Details |
| A13931 | 29683979 | Eur J Gastroenterol Hepatol | Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. | 2018 | Details |
| A13971 | 29664906 | PLoS One | Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study. | 2018 | Details |
| A13977 | 29661561 | J Pediatr | Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13990 | 29655574 | Rev Gastroenterol Mex (Engl Ed) | Current treatment for non-alcoholic fatty liver disease. | 2018 | Details |
| A13994 | 29653359 | J Nutr Biochem | The role of the gut microbiota in the pathology and prevention of liver disease. | 2018 | Details |
| A14007 | 29641459 | Molecules | An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14041 | 29620197 | Mol Med Rep | Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis. | 2018 | Details |
| A14052 | 29609136 | Cytokine | Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses. | 2018 | Details |
| A14093 | 29590715 | Acta Clin Croat | Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A14130 | 29571977 | Diabetes Metab Syndr | Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors. | 2018 | Details |
| A14131 | 29571924 | J Hepatol | High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. | 2018 | Details |
| A14146 | 29564062 | Gastroenterol Hepatol Bed Bench | Protein-protein interaction analysis of Alzheimer`s disease and NAFLD based on systems biology methods unhide common ancestor pathways. | 2018 | Details |
| A14151 | 29562725 | Int J Mol Sci | Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
| A14153 | 29561981 | Arq Gastroenterol | MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY. | 2018 | Details |
| A14159 | 29558460 | Int J Mol Sci | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. | 2018 | Details |
| A14191 | 29537411 | J R Coll Physicians Edinb | Bariatric surgery as a treatment for metabolic syndrome. | 2017 | Details |
| A14274 | 29488485 | Ter Arkh | [Nonalcoholic fatty liver disease without obesity: the problem to be solved]. | 2019 | Details |
| A14293 | 29479443 | Gastroenterol Rep (Oxf) | Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A14305 | 29225776 | F1000Res | The sedentary (r)evolution: Have we lost our metabolic flexibility? | 2017 | Details |
| A14308 | 29471561 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease in Children. | 2018 | Details |
| A14347 | 29453464 | Int J Obes (Lond) | Dietitian-led lifestyle modification programme for obese Chinese adolescents with non-alcoholic fatty liver disease: a randomized controlled study. | 2018 | Details |
| A14352 | 29452135 | Prog Cardiovasc Dis | Evidence-Based Exercise Recommendations to Reduce Hepatic Fat Content in Youth- a Systematic Review and Meta-Analysis. | 2018 | Details |
| A14372 | 29441049 | Front Microbiol | Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14387 | 29432207 | J Pediatr Endocrinol Metab | Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic. | 2018 | Details |
| A14390 | 29431403 | Am Fam Physician | Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. | 2017 | Details |
| A14391 | 29430321 | Liver Res | Interaction between stress responses and circadian metabolism in metabolic disease. | 2017 | Details |
| A14402 | 29427486 | Liver Int | Management of patients with non-alcoholic steatohepatitis (NASH) in real life. | 2018 | Details |
| A14427 | 29411270 | Adv Ther | Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. | 2018 | Details |
| A14435 | 29408694 | J Hepatol | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | 2018 | Details |
| A14450 | 29404483 | Hepatol Commun | Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. | 2017 | Details |
| A14453 | 29404440 | Hepatol Commun | Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. | 2017 | Details |
| A14492 | 29385034 | Nutrients | Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet. | 2018 | Details |
| A14533 | 29366420 | Curr Pediatr Rev | Predictors of Non-Alcoholic Liver Disease in Ethnically Diverse Overweight Children and Adolescents. | 2018 | Details |
| A14534 | 29364302 | Food Funct | Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. | 2018 | Details |
| A14550 | 29358945 | PPAR Res | Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14586 | 29337849 | Antioxidants (Basel) | Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? | 2018 | Details |
| A14596 | 29333610 | Aliment Pharmacol Ther | Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. | 2018 | Details |
| A14652 | 29307987 | World J Gastroenterol | Obese children with fatty liver: Between reality and disease mongering. | 2017 | Details |
| A14665 | 29298969 | Pol Merkur Lekarski | [Dietetary recommendation for non-alcoholic fatty liver disease]. | 2017 | Details |
| A14690 | 29287963 | Clin Breast Cancer | Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients. | 2017 | Details |
| A14692 | 29287685 | Pharmacol Res | Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. | 2017 | Details |
| A14791 | 29231919 | Pol Merkur Lekarski | [Non-alcoholic liver disease - diagnosis and treatment]. | 2017 | Details |
| A14797 | 29227069 | Fukuoka Igaku Zasshi | Molecular Mechanism of Lifestyle-related Diseases : See Both the Wood and Trees! | 2016 | Details |
| A14799 | 29226105 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Clinical Update. | 2017 | Details |
| A14813 | 29222911 | Hepatology | Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2018 | Details |
| A14856 | 29202557 | Korean J Intern Med | Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. | 2017 | Details |
| A14889 | 29189999 | J Endocrinol Invest | NAFLD/NASH in patients with type 2 diabetes and related treatment options. | 2017 | Details |
| A14941 | 29164049 | J Transl Int Med | Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14961 | 29154966 | J Hepatol | Determinants of fibrosis progression and regression in NASH. | 2017 | Details |
| A15014 | 29128055 | Clin Liver Dis | Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15016 | 29128053 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. | 2017 | Details |
| A15060 | 29114108 | Acta Inform Med | Therapeutic Effects of Curcumin on Ultrasonic Morphological Characteristics of Liver in Patients with Metabolic Syndrome. | 2017 | Details |
| A15063 | 29113510 | Diab Vasc Dis Res | Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. | 2017 | Details |
| A15073 | 29108205 | Zhonghua Gan Zang Bing Za Zhi | [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China]. | 2017 | Details |
| A15074 | 29108191 | Zhonghua Gan Zang Bing Za Zhi | [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017]. | 2017 | Details |
| A15085 | 29104232 | Antioxidants (Basel) | Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. | 2017 | Details |
| A15120 | 29085788 | J Transl Int Med | Effect of Pentoxifylline on Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A One Year Randomized Control Trial. | 2017 | Details |
| A15123 | 29085206 | World J Gastroenterol | Nonalcoholic fatty liver disease: Evolving paradigms. | 2017 | Details |
| A15124 | 29085205 | World J Gastroenterol | Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. | 2017 | Details |
| A15159 | 29067150 | Frontline Gastroenterol | Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey. | 2017 | Details |
| A15168 | 29065499 | Diseases | An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15174 | 29063908 | Am J Gastroenterol | Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance. | 2017 | Details |
| A15184 | 29058997 | Annu Rev Pharmacol Toxicol | Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. | 2017 | Details |
| A15186 | 29057834 | Nutrients | Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper. | 2017 | Details |
| A15210 | 29046007 | Dtsch Med Wochenschr | [Dietary Recommendations in Metabolic Vascular Syndrome]. | 2017 | Details |
| A15271 | 28993031 | Trends Mol Med | Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders. | 2017 | Details |
| A15285 | 28987260 | Clin Liver Dis | Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15286 | 28986720 | Curr Atheroscler Rep | The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement. | 2017 | Details |
| A15290 | 28985395 | ILAR J | Nonhuman Primates and Translational Research-Cardiovascular Disease. | 2017 | Details |
| A15305 | 28972878 | Discov Med | Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. | 2017 | Details |
| A15346 | 28954437 | Nutrients | Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. | 2017 | Details |
| A15359 | 28947639 | J Investig Med | Influence of dietary macronutrients on liver fat accumulation and metabolism. | 2017 | Details |
| A15376 | 28939830 | Sci Rep | Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. | 2017 | Details |
| A15380 | 28937599 | Nutrients | Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15386 | 28935446 | Mitochondrion | Mitochondrial adaptation in steatotic mice. | 2017 | Details |
| A15390 | 28933748 | Nutrients | Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15409 | 28925934 | J Clin Med | Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)? | 2017 | Details |
| A15426 | 28918614 | Acta Med Iran | Modifiable Co-Morbidities Trends During Hospital Admissions for Obesity in France (2009-2014). | 2017 | Details |
| A15430 | 28918170 | Clin Nutr | Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. | 2017 | Details |
| A15438 | 28906453 | Nutrients | Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. | 2017 | Details |
| A15442 | 28905102 | Arch Dermatol Res | Digestive system in psoriasis: an update. | 2017 | Details |
| A15459 | 28895929 | Nutrients | Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis. | 2017 | Details |
| A15465 | 28894517 | Middle East J Dig Dis | Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2017 | Details |
| A15511 | 28868179 | World J Gastrointest Pathophysiol | Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients. | 2017 | Details |
| A15549 | 28847977 | Cancer Prev Res (Phila) | Caloric Restriction Prevents Carcinogen-Initiated Liver Tumorigenesis in Mice. | 2017 | Details |
| A15554 | 28845983 | J Med Chem | A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15569 | 28840257 | Diabetologia | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. | 2017 | Details |
| A15621 | 28804621 | Biomed Rep | Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. | 2017 | Details |
| A15624 | 28803504 | Expert Rev Clin Pharmacol | The pharmacological management of NAFLD in children and adolescents. | 2017 | Details |
| A15633 | 28797988 | Turk J Gastroenterol | Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. | 2017 | Details |
| A15649 | 28789631 | BMC Gastroenterol | Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. | 2017 | Details |